Moedas / AMRX
AMRX: Amneal Pharmaceuticals Inc - Class A
9.56
USD
0.01
(0.10%)
A taxa do AMRX para hoje mudou para 0.10%. Paralelamente, o preço mais baixo no mercado atingiu 9.41 e o mais alto foi 9.58.
Veja a dinâmica do par de moedas Amneal Pharmaceuticals Inc - Class A. As cotações em tempo real ajudam a reagir rapidamente aos movimentos do mercado. Ao alternar entre os diferentes períodos de tempo, você pode monitorar tendências e movimentos de preços por minuto, hora, dia, semana ou mês. Use estas informações para prever os movimentos do mercado e tomar decisões de negociação informadas.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
AMRX Notícias
- Rigel Pharmaceuticals, Inc. (RIGL) Soars to 52-Week High, Time to Cash Out?
- Amneal Pharmaceuticals stock hits 52-week high at 9.71 USD
- Amneal Pharmaceuticals stock hits 52-week high at 9.48 USD
- Wall Street Analysts See a 27.66% Upside in Amneal (AMRX): Can the Stock Really Move This High?
- Are Medical Stocks Lagging Boston Scientific (BSX) This Year?
- Here's Why Momentum in Amneal (AMRX) Should Keep going
- Amneal (AMRX) Q2 EPS Jumps 56%
- Amneal (AMRX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
- Amneal Pharmaceuticals (AMRX) Q2 Earnings Top Estimates
- Amneal Pharma A earnings beat by $0.08, revenue fell short of estimates
- Amneal Pharmaceuticals beats Q2 estimates, raises full-year outlook
- Viatris Poised to Report Q2 Earnings: What's in Store for the Stock?
- Nektar Gears Up to Report Q2 Earnings: What's in the Cards?
- Bio-Techne Q4 Earnings Preview: What's in Store for the Stock?
- Amneal (AMRX) is an Incredible Growth Stock: 3 Reasons Why
- Amneal Pharmaceuticals (AMRX) Earnings Expected to Grow: Should You Buy?
- Wall Street Analysts Think Amneal (AMRX) Could Surge 43.82%: Read This Before Placing a Bet
- Is Amneal Pharmaceuticals (AMRX) Outperforming Other Medical Stocks This Year?
- Amneal Pharmaceuticals prices $600 million in senior secured notes, increases term loan
- Amneal seeks to borrow $1.8 billion in new term loans, offers notes
- Jazz Pharmaceuticals: I See Big Potential In This Stock As An Investor (NASDAQ:JAZZ)
- Amneal reports positive phase 3 results for XOLAIR biosimilar
- Amneal Pharmaceuticals director Patel sells $761k in stock
- Organon Stock: Persistent Headwinds Make This A Hold (NYSE:OGN)
Faixa diária
9.41
9.58
Faixa anual
6.69
9.79
- Fechamento anterior
- 9.55
- Open
- 9.57
- Bid
- 9.56
- Ask
- 9.86
- Low
- 9.41
- High
- 9.58
- Volume
- 2.957 K
- Mudança diária
- 0.10%
- Mudança mensal
- 23.83%
- Mudança de 6 meses
- 9.89%
- Mudança anual
- 11.94%
31 agosto, domingo